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Abstract
Background: Fire blight is an important disease affecting rosaceous plants. The causal agent is the bacteria Erwinia
amylovora which is poorly controlled with the use of conventional bactericides and biopesticides. Antimicrobial
peptides (AMPs) have been proposed as a new compounds suitable for plant disease control. BP100, a synthetic
linear undecapeptide (KKLFKKILKYL-NH2), has been reported to be effective against E. amylovora infections.
Moreover, BP100 showed bacteriolytic activity, moderate susceptibility to protease degradation and low toxicity.
However, the peptide concentration required for an effective control of infections in planta is too high due to
some inactivation by tissue components. This is a limitation beause of the high cost of synthesis of this compound.
We expected that the combination of BP100 with lysozyme may produce a synergistic effect, enhancing its activity
and reducing the effective concentration needed for fire blight control.
Results: The combination of a synhetic multifunctional undecapeptide (BP100) with lysozyme produces a
synergistic effect. We showed a significant increase of the antimicrobial activity against E. amylovora that was
associated to the increase of cell membrane damage and to the reduction of cell metabolism. Combination of
BP100 with lysozyme reduced the time required to achieve cell death and the minimal inhibitory concentration
(MIC), and increased the activity of BP100 in the presence of leaf extracts even when the peptide was applied at
low doses. The results obtained in vitro were confirmed in leaf infection bioassays.
Conclusions: The combination of BP100 with lysozyme showed synergism on the bactericidal activity against E.
amylovora and provide the basis for developing better formulations of antibacterial peptides for plant protection.
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Background
Fire blight is an economically important disease affecting
rosaceous plants. The causal agent is Erwinia amylovora
that infects mainly apple and pear as well as a broad
range of woody ornamental plants. Control of disease is
conducted by an integrated management based on the
treatment with antibiotics or copper derivatives
combined with the use of appropriate cultural measures
[1, 2] and with biocontrol agents [3–5]. However,
development of new active compounds with low
phytotoxicity, reduced environmental impact and broad
spectrum of activity is still required.
Antimicrobial peptides (AMPs) appear as a new class
of compounds for plant disease control [6, 7]. AMPs are
found in many organisms, including plants, insects, am-
phibians and humans and are components of the innate
immune system. Moreover, some AMPs have been re-
lated to antibiosis in microorganisms [7–11]. Most
AMPs are small and cationic peptides with the capactiy
to adopt an amphipathic conformation [12, 13]. Their
antimicrobial activity has been extensively related with
the capacity to interact with the cell membranes [14].
This mode of action confers a broad spectrum of action,
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mainly against bacteria and fungi, and allows the
penetration of peptide into the cell, favouring other
mechanisms of action targeting nucleic acids and
proteins [15–20].
The activity of antimicrobial peptides against pathogen
infections in plants, including postharvest products, have
been reported [21–24]. As a result of our research focused
on the development of new antimicrobial agents, linear
undecapeptides (CECMEL11) were disgned using a com-
binatorial approach. Screening of the CECMEL11 library
allow us to identify peptides with activity against several
plant pathogenic bacteria including Erwinia amylovora,
Pseudomonas syringae pv. syringae, Xanthomonas axono-
podis pv. vesicatoria and fungi like Penicillium expansum
[23, 25, 26]. Peptide BP100, KKLFKKILKYL-NH2, was the
most active against bacteria and was effective to inhibit in-
fections caused by E. amylovora in apple and pear flowers.
However, peptide concentrations necessary for the control
of fire blight disease were 10 to 50 times higher than the
minimal inhibitory concentration (MIC) [26]. This de-
crease in the activity in planta has been attributed to the
inactivation by certain plant compounds or structures, or
to their degradation by proteases from plant tissues or
epiphytic microorganisms [27, 28].
Control of plant diseases through the use of antimicro-
bial peptides is a potential complement or alternative to
conventional bactericides, offering more selective and
environmentally friendly products. However, the concen-
trations of these peptides required to control pathogen
infections are generally too high due to the loss of activ-
ity when interact with non-target plant compounds or
structures, or due to their degradation [26–28]. To im-
prove their stability, several strategies have been used in
different peptides and the most common has been to
substitute certain aminoacid residues with non-natural
aminoacids [29, 30]. In the case of BP100, the incorpor-
ation of D-amino acids has increased their stability to
protease degradation and its activity in ex vivo and in
planta assays [31].
However, the improvement of the activity of BP100
through its co-formulation with enhancer compounds
(e.g. lysozyme) seems a reliable strategy. Thus, combin-
ation of nisin with lysozyme has shown a synergistic effect
against Gram positive bacteria [32–34] and lysozyme has
been successfully used as an enhancer of the activity of
GMAP2 against Gram negative bacteria [35]. For this rea-
son, the use of lysozyme as an enhancer of BP100 activity
could be a good strategy because the main mechanism of
action of BP100 seems to be associated to the disruption
of cell membrane [36, 37].
More in detail, to increase the activity of peptides, dif-
ferent approaches have been suggested such as the com-
bination of the peptide with divalent metal cations [38],
with an enzyme [39] or mixtures of peptides with
diferent mode of action [40]. Interestingly the combin-
ation of nisin (a bacteriocin peptide) with lysozyme im-
proved the effect against Listeria monocytogenes [41] and
Clostridium difficile [32]. It has been described also that
the combination of lysozyme with the anionic peptide
GMAP2 showed a syngergistic effect on the activity
against Escherichia coli, Klebsiella pneumoniae and
Pseudomonas aeruginosa [35]. This synergic effect has
been explained by the fact that lyzozyme hidrolyses
ß1-4 bonds between N-acetylglucosamine and N-
acetylmuramic acid damaging the bacterial peptidogly-
cane cell wall which subsequently may facilitate cell
membrane disruption by the AMP [42]. However, the
improvement of the antibacterial activity has not been
previously shown for plant pathogenic bacteria, nor with
the multifunctional synthetic peptide BP100.
In the present work, the effect of the combination of
the multifunctional undecapeptide BP100 with lysozyme
against E. amylovora has been studied. We analyzed the
effect of the combination of BP100 and lysozyme at dif-
ferent doses in the activity against E. amylovora in vitro
by following the integrity of cell membrane and cell via-
bility. Once optimized the dose combination, the effect
of interfering plant extracts was evaluated. Finally, the
synergistic effect of BP100 and lysozyme in the inhib-
ition of infections caused by E. amylovora was confirmed
in wounded pear leaves.
Methods
Peptide synthesis
Peptide BP100 (KKLFKKILKYL-NH2) was synthesized in
the Laboratory of Organic Chemistry of the University
of Girona (LIPPSO) by means of solid-phase synthesis
[26]. BP100 purity was >95% and was determined by
high-performance liquid chromatography (HPLC; Dio-
nex). Peptide identity was confirmed by electrospray
ionization mass spectrometry (ESI-MS; Bruker Dal-
tonics) and matrix-assisted laser desorption ionization-
time-of-flight (MALDI-TOF; Bruker) analysis. Before
use, lyophilized peptide BP100 was dissolved in distilled
water to a concentration of 1 mM and sterilized by
filtration through a 0.22-μm pore-size filter.
Bacterial strains and growth conditions
The non-pathogenic E. amylovora PMV6076 [43] was
used for the analysis of the antibacterial activity in vitro
of BP100 peptide and the combination with lysozyme. E.
amylovora EPS101 was the strain used for the infection
assays [44]. Strains were grown overnight at 25 °C in
Lysogeny Broth agar (LB) (10 g NaCl, 5 g yeast extract,
10 g triptone, pH 7.4). Fresh colonies grown during 24 h
were scraped from the petri dish and suspended in dis-
tilled water previously sterilized. Suitable infections in
incoulated leaves are achieved only with fresh plate
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cultures [45, 46]. Cell suspensions were adjusted to
108 CFU/ml on basis of the optical density (OD) and
serially diluted in sterile distilled water to get the appro-
priate concentration for the experiments.
Viable cell counting
For the viable cells assessment, a method based on the
inoculation of the cell suspension in LB broth and moni-
toring the growth curve was used [47]. The authors
demonstrated that several growth curve parameters, like
the optical density (OD) at a given time, are directly re-
lated to the initial cell concentration. This method was
set-up for E. amylovora in the present work. Several
growth curves using OD were made departing from
known initial cell concentrations determined by plate
counting. The calibration curve consisted of suspensions
of E. amylovora PMV6076 at concentrations from 102 to
108 CFU/ml (confirmed by plate counting). Briefly, 20 μl
samples (threee replicates for each treatment) were
mixed with 180 μl of LB medium in a microplate well
and plates were incubated in the multimode reader with
20 s of shaking during 20 h at 25 °C. OD was measured
each hour at 600 nm. A relationship between the initial
cell concentration by plate counting and the optical
density of the growth curve at 20 h was observed (y =
17.902 · x + 8.814; R2 = 0.97). This relationship was used
to estimate the initial cell concentration of samples dur-
ing the experiments.
Flow cytometry analysis of cell membrane damage
To determine the effect of BP100 on cell membrane, a
SYTOX green based assay was used. The dye only can
penetrate cells with their membrane damaged and sub-
sequently binds DNA producing fluorescence upon exci-
tation with UV light [48]. An aliquot of 160 μl of a
bacterial suspension of E. amylovora PMV6076 adjusted
to 108 CFU/ml were mixed with 20 μl of BP100 (15 μM)
and 20 μl of SYTOX (5 μM). The cell suspension was in-
cubated during 3 h at 25 °C. A control consisting of
20 μl of water was included. Then, bacterial suspensions
were 100 fold diluted in distilled water and analyzed in a
flow cytometer (Sony SH800, Sony Biotechnology Inc.
IL, USA). At least 104 events per sample were measured.
Data were analyzed using SH800 software and scatter-
grams were generated by combining forward scatter
channel (FSC) with SYTOX green fluorescence (Di-
chroic/Splitter, dichroic long-pass: 550 nm, band-pass
filter: 525 nm, detection width 505 to 545 nm).
Bactericidal activity of BP100 combined with lysozyme
The antimicrobial activity of BP100 was determined at
low concentrations (1.0 and 2.5 μM) which are around the
MIC [26], or combined with lysozyme (Sigma Aldrich,
USA) at 0.125, 0.250 and 0.5 mg/ml. The assay was carried
out to determine the membrane damage by SYTOX fluor-
escence and viable cells, simultaneously. For the mem-
brane permeabilization analysis, 160 μl of a suspension of
E. amylovora PMV6076 adjusted to 108 CFU/ml were
mixed with 20 μl SYTOX Green (Life Technologies, Invi-
trogen, Madrid, Spain) at 5 μM and 20 μl of the corre-
sponding treatment (BP100, lysozyme). Controls using
water instead of the peptide were included. Incubation
was performed for 3 h at 25 °C in an automatic spectral
scanning multimode reader (Varioskan, Ascent FL; Lab-
systems, Finland). Uptake of Sytox Green was determined
fluorometrically by measurement at 580 nm after an exci-
tation at 495 nm. Samples were taken at given times of
each mix treatment (BP100, lysozyme) for viable cells con-
centration analysis according to the growth curve method
described above.
In parallel, the samples were viewed with an optical
microscope (NIKON Eclipse Ci-L, NIKON, Germany)
with phase-contrast for total bacteria and blue excitation
light (Nikon B-2A, excitation 450–490 nm, dichroic mir-
ror 505 nm, longpass > 520 nm) for SYTOX fluorescence
stained cells. The images were captured with CCD cam-
era NIKON Digital Sight DS-Fi2 (NIKON, Germany)
using the digital image analysis software NIS elements v
3.22 (NIKON, Germany).
Dose-efect of BP100 alone or combined with lysozyme
The bactericidal activity of BP100 at increasing concen-
trations (0, 1.5, 3.0, 5.0 and 10 μM) alone or combined
with lysozyme (0.05 and 0.5 mg/ml) against E. amylo-
vora was determined by measuring membrane damage,
metabolic activity and survival of cells. In addition to
SYTOX as an indicator of cell membrane damage, resa-
zurin was used as a metabolic activity indicator during
the assay [49]. Briefly, 140 μl of a suspension of E. amy-
lovora PMV6076 (1 × 108 CFU/ml), 20 μl SYTOX Green
at 5 μM, 20 μl of resazurin at 100 μM and 20 μl of the
corresponding treatment (BP100 or lysozyme ten fold
concentrated). Incubation was performed during 3 h at
25 °C in the scanning multimode reader. Membrane
permeabilization and viable cells were determined as
previously described, while metabolic activity was
assessed with the resazurin reduction to resofurin by
fluorometric measurement of the emitted fluorescence
at 595 nm after an excitation at 535 nm. Controls using
water instead of the peptide were included. Three repli-
cates for each treatment were done.
Effect of plant extracts on the activity of peptide BP100
combined with lysozyme
The activity of BP100 alone or combined with lysozyme
(0.5 mg/ml) was evaluated in plant extracts consisting of
young pear leaves (Pyrus communis cv. Conference). A
leaf sample of 1 g was homogenized in 20 mL of 0.05 M
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phosphate buffer (pH 7.0) using a stomacher (Mastica-
tor, IUL Instruments, UK). The extract was then diluted
to 10% in the same buffer, filtered through several layers
of cheesecloth and sterilized by filtration through a filter
of a pore size of 0.20 μm. Then, a contact test was per-
formed by mixing 800 μl of the plant extract with 100 μl
of an E. amylovora suspension at 107 CFU/ml and 100
μl of each treatment (BP100, lysozyme). Water was used
as non-treated control instead of plant extracts. After an
incubation of 3 h at 25 °C, the effect of each treatment
was determined as the remaining viable cells using the
same methodology previously described. Reduction of
viable cells respect to the non-treated control was calcu-
lated in order to determine the inhibitory effect of leaf
extracts on the activity of the treatments. Three repli-
cates for each treatment were done.
Leaf infection assays
The efficacy of BP100 alone (25 and 100 μM) or com-
bined with lysozyme (0.5 mg/ml) was determined in the
inhibition of infections by E. amylovora in detached pear
leaves (P. communis cv. Conference). The youngest
leaves were collected from plants cultivated in the green-
house. Leaves were surface disinfected for 1 min by
immersion in a solution of sodium hypochlorite (1% ac-
tive chlorine). Then leaves were washed twice in distilled
water, and left dry under airflow in a sterile cabinet.
Woundes on the leaves were performed by a double in-
cision (∼1 mm) perpendicular to the midrib. Leaves were
placed over a humidified paper towel inside plastic
boxes. Then, 10 μl of the corresponding treatment were
placed onto each wound, and the treated leaves were left
for 1 h at room temperature. Then, E. amylovora
EPS101 was inoculated in the woundswith 10 μl of a
suspension adjusted at 107 CFU/ml. Leaves were incu-
bated during 5 days at 23 °C and high relative humidity.
Three replicates of of nine leaves per each treatment
were performed. A control inoculated with water, a con-
trol treated with lysozyme at 0.5 mg/ml, and a reference
control treated with streptomycin at 100 μg/ml were in-
cluded. The intensity of infections was evaluated for
each leaf using a severity scale from 0 to 3: 0, no symp-
toms observed; 1, necrosis located around the wound; 2,
necrosis progress far from the wound; and 3, necrosis of
whole leaf [37, 46]. The severity was calculated for each
replicate. Four independent assays were done.
Statistical analysis
Analysis of variance (ANOVA) was used to determine
the effect of the treatments on the activity against E.
amylovora on basis of the general linear model (GLM)
procedure of Statistical Analysis System (SAS) program
(version 8.2; SAS Institute Inc., NC). Tukey’s test was
used to separate the means (P < 0.05).
Fig. 1 Flow cytometry analysis of E. amylovora cells treated with BP100 and stained with SYTOX. Cells suspensions were incubated during 3 h at
25 °C with BP100 at 1.5 μM, and in the presence of SYTOX. A control treated with water was included. Left panels represent the number of events
while the right panels represent the forward scatter channel with SYTOX fluorescence
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Results
Cell membrane damage after exposure to BP100
The effect of BP100 on cell membrane permeability was
studied by using SYTOX staining and flow cytometry
(Fig. 1). Cells exposed to BP100 were classified into a
main group emiting intense fluorescence, and a minor
group emiting low fluorescence, whereas unexposed cells
showed only very low fluorescence. The intense fluores-
cence peak was narrow indicating that most cells emit-
ted similar fluorescence intensity. The forward scatter
channel showed that the size and morphology of the ma-
jority of cells was similar between treated and non-
treated cells. Thus, cells treated with BP100 incorporated
the SYTOX dye into the cytosol (targetting DNA), but
cell morphology and size were not modified compared
to non-treated cells.
Bactericidal activity of BP100 combined with lysozyme
The effect of the combination of BP100 with lysozyme
was determined using a contact assay where cell viability
and membrane permeation were determined simultan-
eously (Fig. 2). It can be observed that BP100 or lysozyme
alone at the concentrations tested were not active. At
1.0 μM BP100, the effect of the addition of lysozyme was
only observed at 0.5 mg/ml (F = 9.2; p < 0.002), while at
2.5 μM the effect on the growth inhibition was significant
at all lysozyme concentrations (F = 253.1; p < 0.0001). As
well as for cell viability similar results were observed for
SYTOX fluorescence. Non treated cells presented the nor-
mal morphology and absence of fluorescence, while cells
treated with lysozyme showed an altered morphology and
a baseline fluorescence level (Fig. 3). However, cells
treated only with BP100 at 2.5 μM maintained normal
morphology but with a strong fluorescence. Cells treated
with the combination of BP100 and lysozyme presented
Fig. 2 Effect of lysozyme on the activity of BP100 against E.
amylovora. The activity was determined using viable cells and SYTOX
fluorescence of E. amylovora suspensions (108 CFU/ml) treated
during 1 h with water or BP100 at 1.0 and 2.5 μM, combined with
lysozyme at 0 (□), 0.125 (□), 0.250 (gray square) and 0.5 (■) mg/ml
Fig. 3 Fluorecense microscope images of E. amylovora cells stained with SYTOX. E. amylovora cells suspensions (108 CFU/ml) were treated during
1 h with water or BP100 to 2.5 μM, in the presence or absence of lysozyme. Images were taken with an optical microscope using white light
(upper panel) and ultraviolet light (lower panel)
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strong fluorescence with altered morphology adopting
spherical appearance, and a tendency to form aggregates.
The effect of BP100 alone or combined with lysozyme
was also tested using a contact assay where viable cells,
cell membrane damage and metabolic activity were
determined simultaneously (Fig. 4). When the concen-
tration of BP100 increased, the viable cells decreased ex-
ponentially (from 108 CFU/ml without BP100 to less
than 104 CFU/ml at 10 μM). This decrease was clearly
enhanced by lysozyme with a reduction of viable cells of
1.5 to 2.0 logs. The effect was more evident at the lower
doses of BP100. SYTOX and resazurin measurements
showed also similar effects. Thus, SYTOX fluorescence
increased when BP100 was combined with lysozyme,
while resazurin fluorescence decreased, in both cases in-
dicating membrane damage that simultaneously decrease
the metabolic activity of cells.
The interference of leaf extracts on the activity of
BP100, alone or combined with lysozyme, was also studied
(Fig. 5). In this assay, different doses of BP100 (0.625, 1.25,
Fig. 4 Dose-effect of BP100 alone or combined with lysozyme in
the antibacterial activity against E. amylovora. The effect was
measured as viable cells (a), SYTOX green fluorescence (b) and
resazurin fluorescence (c) of E. amylovora suspensions (108 CFU/ml).
Treatments consisted of 1 h with BP100 at 0, 1.0, 2.5, 5.0 and 10.0
μM, combined with lysozyme at 0 (●), 0,05 (■), 0,50 (□) mg/ml
Fig. 5 Influence of leaf extract on the antibacterial activity of BP100
alone or combined with lysozyme. The effect was measured as the
growth inhibition of E. amylovora suspension in each treatment
respect the nontreated control after exposure to 2.5, 1.25 and 0.625
μM peptide concentrations without lysozyme or with lysozyme
0.50 mg/ml. The peptide assay was carried out in water (□) or in
pear leaf extracts diluted at 10% (gray square). Two independent
experiments, assay 1 (a) and assay 2 (b), were performed. The
confidence intervals for the means are indicated on top of the bars.
Letters over the bars indicate the significance of the difference
between treatment extracts (P ≤ 0.05), according to
Waller-Duncan’s test
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2.5 and 10 μM), alone or combined with lysozyme at
0.5 mg/ml, were used. The activity of BP100 on the reduc-
tion of cell viability was decreased significantly by the
presence of leaf extracts (F = 134.4, p < 0.001). For ex-
ample, in the first experiment, the reduction of viable cells
by BP100 treatment was of 2.38 log in water, while only of
0.81 log in the presence of leaf extracts. The reduction
was variable among treatments, but in all the cases the in-
hibition of E. amylovora was reduced in the presence of
leaf extracts. However, the combination of BP100 with
lysozyme recovered completely or partially the effect of
BP100. Interestingly, the effect of the combination of
BP100 at 0.625 μM with lysozyme was similar to the treat-
ment with BP100 alone at 2.5 μM. Lysozyme alone
showed no significant activity. These results were consist-
ent in both experiments.
Inhibition of leaf infection by BP100 combined with
lysozyme
The effect of BP100 applied preventively, alone or com-
bined with lysozyme, on the inhibition of infections of E.
amylovora in pear leaves was determined in four assays
(Figs. 6 and 7). In the first and second experiment, results
were similar and the severity of infections in the non-
treated control were 2.1 and 1.7, respectively. In both
experiments, only the treatments based on streptomycin
and BP100 at 25 μM combined with lysozyme, showed
significant decrease in severity with respect to the non-
treated control (F = 18.2; p < 0.0001 and F = 16.7, p <
0.0001). Treatments based on lysozyme and BP100 alone
did not show differences with the non-treated control.
Similar results were observed in the third and fourth
experiments though the severity in the non-treated con-
trols was higher than in the previous assays, with values of
2.7 and 2.6, respectively. Significant differences were also
observed between BP100 at 100 μM combined with lyso-
zyme and the non-treated control (F = 36.9; p < 0.0001
and F = 25.2, p < 0.0001). Lysozyme alone did not show
reduction in disease severity, and BP100 alone only pre-
sented significant differences with the non-treated control
in the third experiment.
Globally, BP100 alone did not have any effect at
25 μM compared to non-treated controls, but it was
effective at 100 μM in one out of four experiments.
Lysozyme alone had no significant effect in the four as-
says compared to the non-treated control. However, the
efficacy of BP100 at either 25 or 100 μM was signifi-
cantly enhanced by lysozyme in all four assays. Interest-
ingly, in one assay the effect of BP100 combined with
lysozyme did not differ significantly from streptomycin.
Fig. 6 Effect of the preventive application of BP100 and lysozyme in the control of E. amylovora infections on pear leaves. BP100 was applied at
different concentrations, alone or combined with lysozyme, in detached pear leaves, just 1 h before the inoculation with a suspension of E.
amylovora (108 CFU/ml). Nontreated control (NTC), lysozyme control and reference treatment with streptomycin were included. Four independent
experiments (a, b, c and d) were performed. The confidence intervals for the means are indicated on top of the bars. Different letters over a bar
indicate a significant difference from the nontreated control for a given experiment, according to Waller-Duncan's test (P < 0.05)
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Discussion
In the present work we have shown that the bactericidal
effect of BP100 is enhanced by lysozyme. Our results
confirm that the bactericidal effect of BP100 against E.
amylovora is mainly associated to the disruption of the
bacterial cell membranes in agreement with some stud-
ies performed with BP100 in artificial membranes [36,
37, 50]. Some of these studies conclude that BP100 oper-
ates via a carpet mechanism, where peptide penetrates
into the hydrophobic core of the bilayer producing a
membrane alteration and consequently changing the
membrane permeability [51]. The same conclusion has
been obtained in the case of CecXJ-37 N, a cationic peptide
similar to cecropin, demonstrating that the peptide induced
pore-formation, morphological changes and lysed E. coli
cells [52]. In addition, other authors reported the capacity
of a cecropin A-magainin hybride peptide to destroy the in-
tegrity of the bacterial cell membrane [53].
In relation with the increase of the activity of BP100
when combined with lysozyme, similar results were ob-
tained in some works showing that the combination of the
bacteriocin nisin with lysozyme had a synergistic effect
against Gram positive bacteria [32–34] or that the com-
bination of lysozyme with the GMAP2 peptide enhances
the activity against several Gram negative bacteria like
Escherichia coli, Klebsiella pneumoniae, Pseudomonas aer-
uginosa and Salmonella typhimurium [35]. Interestingly,
other studies reported that the combination of nisin and
lysozyme caused a rapid depolarization of the cytoplasmic
membranes of Staphylococcus aureus [31].
The increase of the bactericidal effect of BP100 com-
bined with lysozyme was due to the irreversible cell mem-
brane damage causing a decrease in metabolic activity
(resazurin-redution) and cell death. With this combin-
ation, MIC was reduced four times compared to BP100
alone and cell death rate increased. The enhacement of
the bactericidal activity when combined BP100 with lyso-
zyme, can be explained because of the potential affinity of
BP100 with the murein or with some anionic components
present in the outer membrane like lipoproteins [54] or
lipopolysaccharides [55], that probably reduce the avail-
able molecules of BP100 that can interact with the correct
target, in this case the inner cell membrane. Thus, the fact
that lysozyme hydrolyses murein [56], could favor that
BP100 molecules don’t interact with these cell wall
components and could better interact with the inner cell
membrane. This hypothesis could explain that lower con-
centrations of BP100 combined with lysozyme presented
similar activity than BP100 alone four times concentrated.
These results are in agreement with the report that anti-
microbial activity of peptide parasin I was enhanced by lyso-
zyme [57]. The authors suggest that lysozyme could allow
the access of parasin I to the cytoplasmic membrane thanks
to the lysis of peptidoglycan. Moreover, microscopy studies
performed in the present work also reinforce this hypoth-
esis, because the combination of BP100 with lysozyme pro-
duced spherical cell morphologies and cell aggregates.
Spherical cell morphology in several Gram negative bacteria
caused by lysozyme has been previously reported in the case
of E. coli [58] or by combination of lysozyme with high pres-
sure treatments [59]. In addition, the formation of cell ag-
gregates has been reported by treatment with antimicrobial
peptides in early stages before the lysis of the cells [60, 61].
The above reports support the hypothesis that the effect of
both, BP100 and lysozyme, may be mainly associated to an
alteration of the cell envelope.
A decrease of the bactericidal activity of BP100 against
E. amylovora was observed in plant extracts compared
to water solutions, in agreement with other reports for
Fig. 7 Fire blight symptoms in pear leaves submitted to different
treatments with lysozyme and BP100. a Wounded leaves were treated
with 10 μl of either, water (NTC), BP100 at 100 μM, lysozyme, or BP100
at 25 μM combined with lysozyme. Then, wounds were inoculated
with 10 μl of a suspension of E. amylovora EPS101 at 107 UFC/ml.
Assessment of symptoms was performed after 5 days of incubation at
23 °C under high relative humidity. b Scale of severity of infections
according to the symptoms observed: 0, no symptoms; 1, leaf necrosis
localized around the wound; 2, necrosis progression far from the
wound; and 3, necrosis extended to most part of the whole leaf
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the antimicrobial peptides cecropin B and SB-37 [62],
Pep11 and Pep20 [28], Pep3 [27] and several CECMEL11
peptides [26]. However, the combination of BP100 pep-
tide with lysozyme increased its activity in the presence
of leaf extracts. This effect was confirmed by leaf infec-
tion assays in which the efficacy of BP100 was signifi-
cantly enhanced by lysozyme, and in one case the effect
did not differ from the antibiotic streptomycin. Interest-
ingly, the concentration of BP100 at 25 μM in the pres-
ence of lysozyme provided similar efficacy of control
than the concentrations of 100–200 μM previously re-
ported when BP100 is applied alone [26].
Conclusions
The combination of BP100 peptide with lyzozyme in-
creases the bactericidal activity of BP100 against E. amylo-
vora, even in the presence of plant extracts, and enhances
the protection against fire blight infections in plant mater-
ial. These results provide the basis for a better formulation
of antimicrobial peptides for plant protection.
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